AeroLeads people directory · profile
Aaron Schacht Email & Phone Number
Independent Director
at
Redux Bio
2 work emails found
@elanco.com
5 phones found area 317, 765, and 865
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Independent Director
Location
Greater Indianapolis, United States, United States
Company size
Who is Aaron Schacht? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Aaron Schacht is listed as Independent Director at Redux Bio, a company with 7 employees, based in Greater Indianapolis, United States, United States. AeroLeads shows a work email signal at elanco.com, phone signal with area code 317, 765, 865, and a matched LinkedIn profile for Aaron Schacht.
Aaron Schacht previously worked as Chief Executive Officer and Board Director at Biomedit and Member Board of Directors at Gallant Therapeutics. Aaron Schacht holds Bs, Chemistry from University Of Illinois Urbana-Champaign.
Company email context
Email format at Redux Bio
This section adds company-level context without repeating Aaron Schacht's masked contact details.
*@elanco.com
71% confidence
AeroLeads found 2 current-domain work email signals for Aaron Schacht. Compare company email patterns before reaching out.
Profile bio
About Aaron Schacht
30 years transforming projects, portfolios and companies, the next 20 years transforming an industry.With over 30 years of experience in the life sciences industry, I am a seasoned executive leader and entrepreneur who is passionate about driving innovation and creating value for patients, customers, and stakeholders. As the CEO and Board Director of BiomEdit, a biotechnology company focused on animal health product innovation leveraging the science of the microbiome and synthetic biology, I lead a team of talented scientists and business professionals who are committed to developing novel solutions for some of the most pressing challenges in animal health and welfare.My core competencies include drug discovery and development, R&D strategy and transformation, business development and licensing, mergers and acquisitions, venture capital and private equity, and external R&D and open innovation. I have a proven track record of delivering results and achieving growth, having led or been involved in envisioning, forming, funding, and starting up several venture-funded companies, as well as executing nearly $8.5B in M&A transactions with Elanco Animal Health. I also serve on the boards of several for-profit and non-profit organizations in the life sciences and biotechnology sectors, where I leverage my expertise and network to support their missions and goals.
Listed skills include Pharmaceutical Industry, Drug Discovery, Drug Development, Strategy, and 34 others.
Current workplace
Aaron Schacht's current company
Company context helps verify the profile and gives searchers a useful next step.
Redux Bio
24 roles
Aaron Schacht work experience
A career timeline built from the work history available for this profile.
Chief Executive Officer And Board Director
CurrentBiomEdit is a biotechnology company focused on animal health product innovation leveraging the science of the microbiome and synthetic biology to address significant challenges in animal health.
Apr 2022 - Present
Member Board Of Directors
Current
Feb 2024 - Present
Independent Director
Current
Mar 2022 - Present
Board Member
Current
Jan 2021 - Present
Board Member & Chairman Emeritus
Jan 2016 - Dec 2023
Non Executive Director
Feb 2022 - Nov 2023
President/Ceo
Mbrd Service Company, Llc
MBRD Service Company LLC was originally the entity established with a primary purpose to facilitate the carveout of Elanco's leading edge microbiome R&D platform and pipeline. Established in January of 2022 with the team of expert scientists, product developers, regulatory experts and business leaders from Elanco. MBRD focuses on providing.
Dec 2021 - Apr 2022
Executive Vice President - Elanco Animal Health
Led strategic initiative to carve out Elanco's Microbiome R&D platform into privately funded venture.Retired from Elanco
Oct 2021 - Dec 2021
Executive Vice President - Innovation, Regulatory & Business Development
Aaron Schacht served as executive vice president, Innovation, Regulatory, and Business Development at Elanco. In this role, he oversaw global R&D, regulatory, business development and nutritional health. Responsible for all internal and external innovation, regulatory affairs, business development & licensing, mergers & acquisitions, and transformational.
Sep 2018 - Oct 2021
Vice President - Global R&D/Regulatory/Bus Dev’T/Nutritional Health
Responsible for discovery research, development, regulatory, external innovation, business development and Elanco Nutritional Health.
Oct 2015 - Sep 2018
Global Brand Development Leader - Pain - Lilly Biomedicines
Lead Product Development/Commercialization for LY2951742 - a novel CGRP Neutralizing Antibody which launched as Emgality in 2018
Feb 2014 - Sep 2015
Sr. Director - Product Development Strategy, Operations & Business Dev'T - Lilly Biomedicines
Strategy, Development Operations, Portfolio Management and Business Development for Lilly BioMedicines Business Unit - Lilly's largest and most comprehensive business unit.Implemented improved TA Strategies, Pipeline/Portfolio Management, Product Development Strategy & Operations, and Business Development Strategies and Processes.
Jan 2012 - Oct 2014
Executive Director & Chief Operating Officer - Global External R&D
- Accomplishments:
- Lead and oversaw strategy and operations of Lilly’s Global External R&D group
- Vanthys: Launched and managed Novel Early Development Joint Venture in India, later acquired by JV partner Jubilant
- Geographic Surveillance efforts in India and Japan
- Developed and Launch Lilly Mirror Funds/Built Lilly Mirror Portfolio, resulting in Artaeus, Dekkun, Anexon, Apofore, Tensha, GITR.
Oct 2008 - Dec 2011
Executive Director - R&D Strategy, Portfolio And Project Management
Executive leader for all efforts in Pipeline/Portfolio Management, Enterprise Resource/Financial Planning and Capacity Analysis, Long Range R&D Strategy and Plan, and Evolution of R&D Project Management capabilities, tools and organization.
Sep 2005 - Sep 2008
Director, Lrl Strategy
Led strategy setting and strategic planning for Lilly Research Laboratories to optimize R&D pipeline.
Jun 2004 - Aug 2005
Director - Elilly Innovation Center
New Venture Creation & Development, New Business Incubation, Innovation Management. Incubated following start-up companies: Indigo Biosystems, Collaborative Drug Discovery, Coalesix, and Maaguzi
Nov 2002 - May 2004
Ceo/Co-Founder
Artesian Therapeutics
Founder and founding CEO for Artesian Therapeutics, a cardiovascular small molecule drug development company focused on dual pharmacophore strategies for developing novel therapies for congestive heart failure. Artesian later acquired by Cardiome Pharma.
Feb 2002 - Nov 2002
Managing Director - Lilly University
Interim leadership for Global Training and Dev't Organization. Developed and launched enterprise e-Learning platform.
Jun 2001 - Feb 2002
Director - Knowledge Management
Founding leader for Lilly Knowledge Management program with specific focus on implementation of enterprise IT capabilities across Lilly for enterprise portal, enterprise content management, exploitation of internet tools.Co-conceived Innocentive with Alph Bingham.
Jan 2000 - May 2001
Manager - Discovery Strategy/Productivity
Led Drug Discovery strategy, portfolio management and transformation initiatives to enhance Lilly Research Laboratories discovery output, producing and sustaining a tripling of drug candidate selection output over 3 year period.
Jan 1997 - Dec 1999
Productivity Projects Associate
Initiated, led and implemented cross-functional discovery process improvement initiatives in Lilly Research Laboratories.
Sep 1995 - Dec 1996
Medicinal Chemist
Medicinal Chemist working in the area of Oral Anticoagulants. Co-Inventor on 17 patents. Co-inventor on patent for Exanta.
Jul 1990 - Aug 1995
Co-Op Education
Co-Op Education Employee for Dow Chemical. Worked in Saran R&D, Design Thermoplastics Research, Versene/Chelants Technical Service
Aug 1986 - Sep 1989
2 education records
Aaron Schacht education
Bs, Chemistry
University Of Illinois Urbana-Champaign
High School, College Prep
Pecatonica High School
FAQ
Frequently asked questions about Aaron Schacht
Quick answers generated from the profile data available on this page.
What company does Aaron Schacht work for?
Aaron Schacht works for Redux Bio.
What is Aaron Schacht's role at Redux Bio?
Aaron Schacht is listed as Independent Director at Redux Bio.
What is Aaron Schacht's email address?
AeroLeads has found 2 work email signals at @elanco.com for Aaron Schacht at Redux Bio.
What is Aaron Schacht's phone number?
AeroLeads has found 5 phone signal(s) with area code 317, 765, 865 for Aaron Schacht at Redux Bio.
Where is Aaron Schacht based?
Aaron Schacht is based in Greater Indianapolis, United States, United States while working with Redux Bio.
What companies has Aaron Schacht worked for?
Aaron Schacht has worked for Redux Bio, Biomedit, Gallant Therapeutics, Indiana Biosciences Research Institute, and Agrinovus Indiana.
How can I contact Aaron Schacht?
You can use AeroLeads to view verified contact signals for Aaron Schacht at Redux Bio, including work email, phone, and LinkedIn data when available.
What schools did Aaron Schacht attend?
Aaron Schacht holds Bs, Chemistry from University Of Illinois Urbana-Champaign.
What skills is Aaron Schacht known for?
Aaron Schacht is listed with skills including Pharmaceutical Industry, Drug Discovery, Drug Development, Strategy, Lifesciences, Start Ups, Biotechnology, and R&D.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial